Sana Biotechnology stockholders re-elect three directors, ratify auditor at annual meeting
Filed June 5, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
low
Stockholders elected Hans E. Bishop, Robert Nelsen, and Alise S. Reicin as Class II directors for three-year terms expiring in 2029, maintaining board continuity.
Item 5.07 verify on EDGAR → -
low
Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 99.6% approval (203.9M votes for vs. 831K against).
Item 5.07 verify on EDGAR →
See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.
Partner
Trade SANA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 8, 2026 4:12 AM